A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.

@article{Dankert2007ARC,
  title={A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.},
  author={Timo Dankert and Jan A. M. Kremer and Ben J. Cohlen and Carl J C M Hamilton and Pieternel C. M. Pasker-de Jong and H. S. Straatman and Peter A van Dop},
  journal={Human reproduction},
  year={2007},
  volume={22 3},
  pages={792-7}
}
BACKGROUND Controlled ovarian hyperstimulation with intrauterine insemination (IUI) is a widely accepted treatment for unexplained and male subfertility. No consensus exists about the drug of first choice to be used as hyperstimulation. This randomized multicentre trial using a parallel design compares the efficacy of clomiphene citrate (CC) with that of recombinant FSH (rFSH). METHODS Couples with primary unexplained or male subfertility were randomized to receive CC or rFSH for ovarian… CONTINUE READING